Governor Huntsman to Host Canadian Biotech Mission & Announce Canada's Newly Appointed Honorary Consul for Utah
Nov 03 2005
Salt Lake City, Utah-Utah Governor Jon Huntsman, Jr. and a delegation from the Consulate General of Canada in Denver will co-host five of Canada's leading biotech firms and a representative from International Trade Canada during the upcoming Utah/Canada Life Science Technology Partnering Symposium. The event will be held on Monday, November 7, 2005, from 8:30 a.m. to 2 p.m. at the Huntsman Cancer Institute in Salt Lake City, Utah. Activities will include welcoming remarks from Governor Huntsman, a keynote lecture, a tour of the Huntsman Cancer Institute and presentations on cost-advantage services and products that Canadian biotech firms can offer Utah's burgeoning life sciences industry.
Following the symposium, Governor Huntsman and a delegation from the Consulate General of Canada-representing the four-state Rocky Mountain region of Colorado, Montana, Wyoming and Utah-will announce local business and community leader Scott Parker as the Government of Canada's newly appointed Honorary Consul of Utah. This evening celebration will be held at the Alta Club, located at 100 East South Temple, from 5 to 7 p.m., and will include many other of Salt Lake's government, business and community leaders as invited guests.
"The Government of Canada is establishing an Honorary Consul in Salt Lake City in order to facilitate mutually beneficial trade and technology links between Utah and Canada with a focus on the life science and information technology sectors," explained Michael Fine, Consul General of Canada, Denver. "Scott Parker's 23-year background as president emeritus of the non-profit Intermountain Health Care-considered to be one of the nation's most successful integrated healthcare delivery systems-provides him with an excellent set of experiences to help the consulate build these important partnerships. Our upcoming biotech mission is the first example of many ventures we hope to accomplish in Utah over the years to come."
The following five Canadian companies will present at the Utah/Canada Life Science Technology Partnering Symposium:
* Global IQ (Edmonton, Alberta) is a world-class clinical research organization that provides pharmaceutical and biotechnology companies with support needed to get product to market quickly and efficiently. Attendees will include Paul Braconnier, president & CEO, Robin Goldston, vice-president of business development, and Rod Szarka, manager of business development. For more information, visit www.globaliq.com.
* ToxTest - Alberta Research Council (Vergreville, Alberta) is a contract research organization (CRO) that provides non-clinical toxicology and safety assessment testing for pharmaceutical, biotechnology and chemical companies. Dr. Margitta Dzwenka, study director, and Gayle Piat, quality assurance manager, will attend. For more information, visit www.arc.ab.ca.
* Novasys (Montreal, Quebec) specializes in the development and distribution of web-based training applications for the life science sector since 1990. Dr. Paul Miller will attend. For more information visit www.trainingofficeaudit.com.
* Canadian Universal Technologies Ltd. (Halifax, Nova Scotia) acts as the industrial arm in the field of bio-medical and other hi-tech products such as hospital and medical devices and supplies. Vethie Ebotoke, CEO, will attend. For more information visit www.needlezone.com.
* QSV Biologics (Edmonton, Alberta) is an international biologics contract manufacturer providing mammalian cell culture, microbial fermentations and purifications services for the production of protein therapeutics, vaccines and diagnostics. Richard Hetrick, business development, will attend. For more information visit www.qsvbiologics.com.
"Canada has a great deal to offer Utah's growing life sciences industry in the biotechnology, medical devices and pharmaceutical sectors. We have a dynamic and growing bioscience industry that ranks among the world's top five nations for developing new bio-technologies, and we have the second highest global concentration of biotechnology companies," explained Monica Heron, consul and senior trade commissioner for the Consulate General of Canada in Denver. "In addition, Canada provides a cost-competitive business environment to conduct clinical trials, research and development and bio-compound production. On average, U.S. companies pay $800 million for clinical trials. In Canada, however, our well established cadre of Contract Research Organizations is able to offer similar high quality services at a savings of more than 20 percent, which means $160 million that Utah biotech companies could use towards other investments."
Discussing his recent appointment as Canada's new Honorary Consul for Utah, Scott Parker expressed that after the upcoming Utah/Canada Life Science Technology Partnering Symposium, he looks forward to continuing to develop closer cultural, academic and economic ties between the State of Utah and the Canadian Provinces. "I am honored that Governor Jon Huntsman placed my name in nomination and that Consul General Michael Fine has given me this great opportunity to represent the Canadian Government in the State of Utah," said the president emeritus of Intermountain Health Care.
Utah businesses that want to participate in this international partnering event should contact Stephen Davis, trade commissioner for the Consulate General of Canada in Denver, at (303) 626-0640 or email@example.com. For press inquiries regarding the Consulate General of Canada in Denver, contact Jennifer Cook, communications officer, at (303) 626-0672 or firstname.lastname@example.org. For all press inquiries directed to Governor Huntsman's office, please contact Tammy Kikuchi, communications director for Utah Governor's Office at (801) 538-1000 or email@example.com.